Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,535Revenue (TTM) $M1,338Net Margin (%)6.0Altman Z-Score3.3
Enterprise Value $M7,071EPS (TTM) $0.3Operating Margin %7.4Piotroski F-Score4
P/E(ttm)85.1Beneish M-Score-2.8Pre-tax Margin (%)4.3Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %2.9Quick Ratio2.9Cash flow > EarningsY
Price/Sales5.05-y EBITDA Growth Rate %1.9Current Ratio3.4Lower Leverage y-yN
Price/Free Cash Flow26.8y-y EBITDA Growth Rate %-15.5ROA % (ttm)1.9Higher Current Ratio y-yN
Dividend Yield %--PEG45.5ROE % (ttm)3.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M226ROIC % (ttm)2.8Gross Margin Increase y-yN

Gurus Latest Trades with QGEN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

QGEN is held by these investors:

QGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about QGEN :

Quarterly/Annual Reports about QGEN:

    News about QGEN:

    Articles On GuruFocus.com
    David Herro's Oakmark International Small Cap Fund 4th Quarter Commentary Jan 08 2016 
    Biotech Gets Personal: Long on Qiagen (QGEN) & SPDR S&P Biotech (XBI) Feb 29 2012 
    Guru Stocks at 52-Week Lows: LMT, VIP, VMC, IRM, QGEN Oct 10 2010 
    Weekly Guru Bargains Highlights: QGEN, BXS, ATHR, LYV, TFSL Oct 09 2010 

    More From Other Websites
    QIAGEN NV Financials Mar 09 2017
    QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : March 6, 2017 Mar 06 2017
    New Study Published in Lancet Respiratory Medicine Highlights QIAGEN's QuantiFERON-TB Potential to... Feb 16 2017
    QIAGEN NV :QGEN-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017 Feb 08 2017
    QIAGEN NV :QGEN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017 Feb 06 2017
    QIAGEN (QGEN) Earnings Meet, Sales Miss Estimates in Q4 Feb 03 2017
    Edited Transcript of QGEN earnings conference call or presentation 2-Feb-17 2:00pm GMT Feb 02 2017
    Qiagen meets 4Q profit forecasts Feb 01 2017
    Qiagen meets 4Q profit forecasts Feb 01 2017
    QIAGEN Reports Results for Fourth Quarter and Full-year 2016 Feb 01 2017
    QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : February 1, 2017 Feb 01 2017
    Q4 2016 Qiagen NV Earnings Release - 4:00 pm ET Feb 01 2017
    QIAGEN Hereditary and Rare Disease Solution Chosen by Genomics England Jan 30 2017
    QIAGEN's QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits Jan 26 2017
    QIAGEN Announces Adjustment of Conversion Ratio Under its 0.375% Senior Unsecured Convertible Notes... Jan 26 2017
    QIAGEN NV – Value Analysis (NASDAQ:QGEN) : January 19, 2017 Jan 19 2017
    QIAGEN Announces Details for Completion of Approximately $250 Million Synthetic Share Repurchase Jan 18 2017
    QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : January 18, 2017 Jan 18 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)